Skip to content
2000
Volume 26, Issue 3
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Breast cancer is one of the most common malignancies affecting women worldwide. It is a complex, heterogeneous disease, classified into several subtypes, including hormone receptor-positive and triple-negative breast cancer (TNBC), each with distinct therapeutic challenges. TNBC, in particular, is characterized by its aggressive nature and lack of targeted therapies due to the absence of estrogen, progesterone, and HER2 receptors. This review explores the potential of natural plant-based compounds, especially focusing on Clove Basil () and , in combating breast cancer. These plants have been traditionally used for their medicinal properties and are now being studied for their anticancer effects. has demonstrated significant antiproliferative and pro-apoptotic effects against breast cancer cells, particularly the MCF-7 line, through mitochondrial pathway activation and gene regulation. Similarly, exhibits potential through its rich content of flavonoids and other bioactive compounds, which have been shown to induce apoptosis, reduce tumor growth, and offer antioxidant benefits. The review highlights how these plant extracts, with their multiple mechanisms, including immune modulation and direct cytotoxic effects, hold promise as adjunctive or alternative therapies in breast cancer treatment, particularly for hard-to-treat subtypes like TNBC. Continued research into their molecular pathways and therapeutic efficacy could lead to new, less toxic treatment options.

© 2026 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206375507250603074251
2025-06-11
2026-03-03

  • From This Site

    /content/journals/acamc/10.2174/0118715206375507250603074251
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/acamc/26/3/ACAMC-26-3-02.html?itemId=/content/journals/acamc/10.2174/0118715206375507250603074251&mimeType=html&fmt=ahah

References

  1. PetrovskaB. Historical review of medicinal plants′ usage.Pharmacogn. Rev.20126111510.4103/0973‑7847.95849 22654398
     [Google Scholar]
  2. CosmeP. RodríguezA.B. EspinoJ. GarridoM. Plant phenolics: Bioavailability as a key determinant of their potential health-promoting applications.Antioxidants2020912126310.3390/antiox9121263 33322700
     [Google Scholar]
  3. Linnewiel-HermoniK. KhaninM. DanilenkoM. ZangoG. AmosiY. LevyJ. SharoniY. The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity.Arch. Biochem. Biophys.2015572283510.1016/j.abb.2015.02.018 25711533
     [Google Scholar]
  4. HabliZ. ToumiehG. FatfatM. RahalO. Gali-MuhtasibH. Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms.Molecules201722225010.3390/molecules22020250 28208712
     [Google Scholar]
  5. National action to improve the early detection of breast cancer. 2023. Available from: https://www.uicc.org/news-and-updates/news/national-action-improve-early-detection-breast-cancer
  6. GinsburgO. YipC.H. BrooksA. CabanesA. CaleffiM. Dunstan YatacoJ.A. GyawaliB. McCormackV. McLaughlin de AndersonM. MehrotraR. MoharA. MurilloR. PaceL.E. PaskettE.D. RomanoffA. RositchA.F. ScheelJ.R. SchneidmanM. Unger-SaldañaK. VanderpuyeV. WuT.Y. YumaS. DvaladzeA. DugganC. AndersonB.O. Breast cancer early detection: A phased approach to implementation.Cancer2020126Suppl. 102379239310.1002/cncr.32887 32348566
     [Google Scholar]
  7. Early Detection 2025. Available from: https://www.nationalbreastcancer.org/early-detection-of-breast-cancer/
  8. LoiblS. AndréF. BachelotT. BarriosC.H. BerghJ. BursteinH.J. CardosoM.J. CareyL.A. DawoodS. Del MastroL. DenkertC. FallenbergE.M. FrancisP.A. Gamal-EldinH. GelmonK. GeyerC.E. GnantM. GuarneriV. GuptaS. KimS.B. KrugD. MartinM. MeattiniI. MorrowM. JanniW. Paluch-ShimonS. PartridgeA. PoortmansP. PusztaiL. ReganM.M. SparanoJ. SpanicT. SwainS. TjulandinS. ToiM. TrapaniD. TuttA. XuB. CuriglianoG. HarbeckN. Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up.Ann. Oncol.202435215918210.1016/j.annonc.2023.11.016 38101773
     [Google Scholar]
  9. NagaiH. KimY.H. Cancer prevention from the perspective of global cancer burden patterns.J. Thorac. Dis.20179344845110.21037/jtd.2017.02.75 28449441
     [Google Scholar]
  10. KondovB. MilenkovikjZ. KondovG. PetrushevskaG. BasheskaN. Bogdanovska-TodorovskaM. TolevskaN. IvkovskiL. Presentation of the molecular subtypes of breast cancer detected by immunohistochemistry in surgically treated patients.Open Access Maced. J. Med. Sci.20186696196710.3889/oamjms.2018.231 29983785
     [Google Scholar]
  11. RedigA.J. McAllisterS.S. Breast cancer as a systemic disease: A view of metastasis.J. Intern. Med.2013274211312610.1111/joim.12084 23844915
     [Google Scholar]
  12. AguilarC., M.J. Mur VN. Neri SM. Pimentel-RamírezM.L. García-RilloA. Gómez V.E. Breast cancer and body image as a prognostic factor of depression: A case study in México City.Nutr. Hosp.201431137137910.3305/nh.2015.31.1.7547 25561132
     [Google Scholar]
  13. PanS.Y. ZhouS.F. GaoS.H. YuZ.L. ZhangS.F. TangM.K. SunJ.N. MaD.L. HanY.F. FongW.F. KoK.M. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics.Evid. Based Complement. Alternat. Med.2013201312510.1155/2013/627375 23634172
     [Google Scholar]
  14. LaskarY.B. LourembamR.M. MazumderP.B. Herbal remedies for breast cancer prevention and treatment.Medicinal Plants—Use in Prevention and Treatment of Diseases.London, UKInTech Open202010.5772/intechopen.89669
     [Google Scholar]
  15. LiY. LiS. MengX. GanR.Y. ZhangJ.J. LiH.B. Dietary natural products for prevention and treatment of breast cancer.Nutrients20179772810.3390/nu9070728 28698459
     [Google Scholar]
  16. SoloweyE. LichtensteinM. SallonS. PaavilainenH. SoloweyE. Lorberboum-GalskiH. Evaluating medicinal plants for anticancer activity.ScientificWorldJournal2014201411210.1155/2014/721402 25478599
     [Google Scholar]
  17. Nutrition services for cancer patients. Available from: https://stanfordhealthcare.org/medical-clinics/cancer-nutrition-services/reducing-cancer-risk/antioxidants.html
  18. BriguglioG. CostaC. PollicinoM. GiambòF. CataniaS. FengaC. Polyphenols in cancer prevention: New insights.(Review).Int. J. Funct. Nutr.202012910.3892/ijfn.2020.9
     [Google Scholar]
  19. HuangW.Y. CaiY.Z. ZhangY. Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention.Nutr. Cancer200962112010.1080/01635580903191585 20043255
     [Google Scholar]
  20. SharmaA. KaurM. KatnoriaJ.K. NagpalA.K. Polyphenols in food: Cancer prevention and apoptosis induction.Curr. Med. Chem.201825364740475710.2174/0929867324666171006144208 28990504
     [Google Scholar]
  21. FilettiV. FalzoneL. RapisardaV. CaltabianoR. Eleonora GrazianoA.C. LeddaC. LoretoC. Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation.Ecotoxicol. Environ. Saf.202019811064010.1016/j.ecoenv.2020.110640 32330788
     [Google Scholar]
  22. FengaC. GangemiS. Di SalvatoreV. FalzoneL. LibraM. Immunological effects of occupational exposure to lead.Mol. Med. Rep.20171553355336010.3892/mmr.2017.6381 28339013
     [Google Scholar]
  23. Antioxidants and cancer prevention. 2017. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet
  24. BozorgiA. KhazaeiS. KhademiA. KhazaeiM. Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells.Iran. J. Basic Med. Sci.202023897098310.22038/ijbms.2020.43745.10270 32952942
     [Google Scholar]
  25. AhmadR. AlLehaibiL.H. AlshammariA.K. AlkhaldiS.M. Quality evaluation of the clinical trials for natural products used in cancer: An evidence-based literature review.Appl. Sci.20201022796110.3390/app10227961
     [Google Scholar]
  26. TelangN. Natural products as drug candidates for breast cancer (Review).Oncol. Lett.202326234910.3892/ol.2023.13935 37427344
     [Google Scholar]
  27. ChungS.S. VadgamaJ.V. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.Anticancer Res.20153513946 25550533
     [Google Scholar]
  28. WeiW. RasulA. SadiqaA. SarfrazI. HussainG. NageenB. LiuX. WatanabeN. SelamogluZ. AliM. LiX. LiJ. Curcumol: From plant roots to cancer roots.Int. J. Biol. Sci.20191581600160910.7150/ijbs.34716 31360103
     [Google Scholar]
  29. HuC. LiM. GuoT. WangS. HuangW. YangK. LiaoZ. WangJ. ZhangF. WangH. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.Phytomedicine20195815274010.1016/j.phymed.2018.11.001 31005718
     [Google Scholar]
  30. RahmaniF. AbdeahadH. JaberiN. HanaieR. SoleimaniA. AvanA. KhazaeiM. HassanianS.M. The protective effect of curcumin on thrombin-induced hyper-permeability.Avicenna J. Phytomed.20231319710810.22038/AJP.2022.21025 36698738PMC9840778
     [Google Scholar]
  31. YuanJ.D. ZhuGeD.L. TongM.Q. LinM.T. XuX.F. TangX. ZhaoY.Z. XuH.L. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer. Artif. Cells Nanomed. Biotechnol.,201846sup130231310.1080/21691401.2017.142349529301415
     [Google Scholar]
  32. DaiZ. NairV. KhanM. CiolinoH.P. Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro.Oncol. Rep.201024410871091 20811693
     [Google Scholar]
  33. ChenH.S. BaiM.H. ZhangT. LiG.D. LiuM. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.Int. J. Oncol.20154641730173810.3892/ijo.2015.2870 25647396
     [Google Scholar]
  34. LiuY. ZouT. WangS. ChenH. SuD. FuX. ZhangQ. KangX. Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism.Int. J. Oncol.20164831063107210.3892/ijo.2016.3351 26794366
     [Google Scholar]
  35. MoshiriM. HamidF. EtemadL. Ricin toxicity: Clinical and molecular aspects.Rep. Biochem. Mol. Biol.2016426065 27536698
     [Google Scholar]
  36. LeitzmannM. PowersH. AndersonA.S. European Code against Cancer 4th Edition: Physical activity and cancer. Cancer Epidemiol.,2015(39 Suppl 1), S46-S55.10.1016/j.canep.2015.03.013
     [Google Scholar]
  37. SharmaV. SarkarI.N. Bioinformatics opportunities for identification and study of medicinal plants.Brief. Bioinform.201314223825010.1093/bib/bbs021 22589384
     [Google Scholar]
  38. CuiZ.J. GaoM. QuanY. LvB.M. TongX.Y. DaiT.F. ZhouX.H. ZhangH.Y. Systems pharmacology-based precision therapy and drug combination discovery for breast cancer.Cancers20211314358610.3390/cancers13143586 34298802
     [Google Scholar]
  39. WishartDS Introduction to cheminformatics. Curr. Protoc. Bioinformatics,20071414.11910.1002/0471250953.bi1401s18
     [Google Scholar]
  40. CareyL.A. Through a glass darkly: Advances in understanding breast cancer biology, 2000-2010.Clin. Breast Cancer201010318819510.3816/CBC.2010.n.026 20497917
     [Google Scholar]
  41. ShaoM.M. ChanS.K. YuA.M.C. LamC.C.F. TsangJ.Y.S. LuiP.C.W. LawB.K.B. TanP.H. TseG.M. Keratin expression in breast cancers.Virchows Arch.2012461331332210.1007/s00428‑012‑1289‑9 22851038
     [Google Scholar]
  42. YersalO. BarutcaS. Biological subtypes of breast cancer: Prognostic and therapeutic implications.World J. Clin. Oncol.20145341242410.5306/wjco.v5.i3.412 25114856
     [Google Scholar]
  43. JiaR. LiZ. LiangW. JiY. WengY. LiangY. NingP. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.World J. Surg. Oncol.202018126810.1186/s12957‑020‑02042‑z 33066779
     [Google Scholar]
  44. RakhaE.A. ElsheikhS.E. AleskandaranyM.A. HabashiH.O. GreenA.R. PoweD.G. El-SayedM.E. BenhasounaA. BrunetJ.S. AkslenL.A. EvansA.J. BlameyR. Reis-FilhoJ.S. FoulkesW.D. EllisI.O. Triple-negative breast cancer: Distinguishing between basal and nonbasal subtypes.Clin. Cancer Res.20091572302231010.1158/1078‑0432.CCR‑08‑2132 19318481
     [Google Scholar]
  45. AlluriP. NewmanL.A. Basal-like and triple-negative breast cancers: Searching for positives among many negatives.Surg. Oncol. Clin. N. Am.201423356757710.1016/j.soc.2014.03.003 24882351
     [Google Scholar]
  46. KreikeB. van KouwenhoveM. HorlingsH. WeigeltB. PeterseH. BartelinkH. van de VijverM.J. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.Breast Cancer Res.200795R6510.1186/bcr1771 17910759
     [Google Scholar]
  47. KumarP. AggarwalR. An overview of triple-negative breast cancer.Arch. Gynecol. Obstet.2016293224726910.1007/s00404‑015‑3859‑y 26341644
     [Google Scholar]
  48. SchettiniF. PratA. Dissecting the biological heterogeneity of HER2-positive breast cancer.Breast20215933935010.1016/j.breast.2021.07.019 34392185
     [Google Scholar]
  49. YinL. DuanJ.J. BianX.W. YuS. Triple-negative breast cancer molecular subtyping and treatment progress.Breast Cancer Res.20202216110.1186/s13058‑020‑01296‑5 32517735
     [Google Scholar]
  50. BoseS. ChandranS. MirochaJ.M. BoseN. The Akt pathway in human breast cancer: A tissue-array-based analysis.Mod. Pathol.200619223824510.1038/modpathol.3800525 16341149
     [Google Scholar]
  51. ZakikhaniM. BlouinM.J. PiuraE. PollakM.N. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells.Breast Cancer Res. Treat.2010123127127910.1007/s10549‑010‑0763‑9 20135346
     [Google Scholar]
  52. WangW. EddyR. CondeelisJ. The cofilin pathway in breast cancer invasion and metastasis.Nat. Rev. Cancer20077642944010.1038/nrc2148 17522712
     [Google Scholar]
  53. HuiM. CazetA. NairR. WatkinsD.N. O’TooleS.A. SwarbrickA. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy.Breast Cancer Res.201315220310.1186/bcr3401 23547970
     [Google Scholar]
  54. HabibJ.G. O’ShaughnessyJ.A. The hedgehog pathway in triple‐negative breast cancer.Cancer Med.20165102989300610.1002/cam4.833 27539549
     [Google Scholar]
  55. KuboM. NakamuraM. TasakiA. YamanakaN. NakashimaH. NomuraM. KurokiS. KatanoM. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.Cancer Res.200464176071607410.1158/0008‑5472.CAN‑04‑0416 15342389
     [Google Scholar]
  56. SouzakiM. KuboM. KaiM. KamedaC. TanakaH. TaguchiT. TanakaM. OnishiH. KatanoM. Hedgehog signaling pathway mediates the progression of non‐invasive breast cancer to invasive breast cancer.Cancer Sci.2011102237338110.1111/j.1349‑7006.2010.01779.x 21091847
     [Google Scholar]
  57. ZhouY. Eppenberger-CastoriS. EppenbergerU. BenzC.C. The NFκB pathway and endocrine-resistant breast cancer.Endocr. Relat. Cancer200512Suppl. 1S37S4610.1677/erc.1.00977 16113098
     [Google Scholar]
  58. ZhouJ. ZhangH. GuP. BaiJ. MargolickJ.B. ZhangY. NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells.Breast Cancer Res. Treat.2008111341942710.1007/s10549‑007‑9798‑y 17965935
     [Google Scholar]
  59. GongL. LiY. Nedeljkovic-KurepaA. SarkarF.H. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells.Oncogene200322304702470910.1038/sj.onc.1206583 12879015
     [Google Scholar]
  60. CidadoJ. ParkB.H. Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy.J. Mammary Gland Biol. Neoplasia2012173-420521610.1007/s10911‑012‑9264‑2 22865098
     [Google Scholar]
  61. López-KnowlesE. O’TooleS.A. McNeilC.M. MillarE.K.A. QiuM.R. CreaP. DalyR.J. MusgroveE.A. SutherlandR.L. PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality.Int. J. Cancer201012651121113110.1002/ijc.24831 19685490
     [Google Scholar]
  62. PascualJ. TurnerN.C. Targeting the PI3-kinase pathway in triple-negative breast cancer.Ann. Oncol.20193071051106010.1093/annonc/mdz133 31050709
     [Google Scholar]
  63. PaplomataE. O’ReganR. The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers.Ther. Adv. Med. Oncol.20146415416610.1177/1758834014530023 25057302
     [Google Scholar]
  64. YangS.X. PolleyE. LipkowitzS. New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer.Cancer Treat. Rev.201645879610.1016/j.ctrv.2016.03.004 26995633
     [Google Scholar]
  65. ChandarlapatyS. SakrR.A. GiriD. PatilS. HeguyA. MorrowM. ModiS. NortonL. RosenN. HudisC. KingT.A. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer.Clin. Cancer Res.201218246784679110.1158/1078‑0432.CCR‑12‑1785 23092874
     [Google Scholar]
  66. PierobonM. RamosC. WongS. HodgeK.A. AldrichJ. ByronS. AnthonyS.P. RobertN.J. NorthfeltD.W. JahanzebM. VocilaL. WulfkuhleJ. GambaraG. GallagherR.I. DunetzB. HokeN. DongT. CraigD.W. CristofanilliM. Leyland-JonesB. LiottaL.A. O’ShaughnessyJ.A. CarptenJ.D. PetricoinE.F. Enrichment of PI3K-AKT-mTOR pathway activation in hepatic metastases from breast cancer.Clin. Cancer Res.201723164919492810.1158/1078‑0432.CCR‑16‑2656 28446508
     [Google Scholar]
  67. GhayadS. CohenP. Inhibitors of the PI3K/Akt/mTOR pathway: New hope for breast cancer patients.Recent Patents Anticancer Drug Discov.201051295710.2174/157489210789702208 19751211
     [Google Scholar]
  68. CiruelosG. E.M. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.Cancer Treat. Rev.201440786287110.1016/j.ctrv.2014.03.004 24774538
     [Google Scholar]
  69. ChineduE. OfiliC. Ocimum species: Ethnomedicinal uses, phytochemistry and pharmacological importance.Int. J. Curr. Res. Physiol. Pharmacol.20215211210.31878/ijcrpp.2021.52.01
     [Google Scholar]
  70. MukherjeeN. BhattacharyaN. AlamN. RoyA. RoychoudhuryS. PandaC.K. Expression of concern: Subtype‐specific alterations of the Wnt signaling pathway in breast cancer: Clinical and prognostic significance.Cancer Sci.2012103221022010.1111/j.1349‑7006.2011.02131.x 22026417
     [Google Scholar]
  71. LohY.N. HedditchE.L. BakerL.A. JaryE. WardR.L. FordC.E. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.BMC Cancer201313117410.1186/1471‑2407‑13‑174 23547709
     [Google Scholar]
  72. VoducK.D. NielsenT.O. PerouC.M. HarrellJ.C. FanC. KenneckeH. MinnA.J. CrynsV.L. CheangM.C.U. αB-crystallin expression in breast cancer is associated with brain metastasis.NPJ Breast Cancer2015111501410.1038/npjbcancer.2015.14 27656679
     [Google Scholar]
  73. BoralD. VishnoiM. LiuH.N. YinW. SprouseM.L. ScamardoA. HongD.S. TanT.Z. ThieryJ.P. ChangJ.C. MarchettiD. Molecular characterization of breast cancer CTCs associated with brain metastasis.Nat. Commun.20178119610.1038/s41467‑017‑00196‑1 28775303
     [Google Scholar]
  74. ChungB. EsmaeiliA.A. Gopalakrishna-PillaiS. MuradJ.P. AndersenE.S. KumarR.N. SrinivasanG. ArmstrongB. ChuC. KimY. TongT. WaismanJ. YimJ.H. BadieB. LeeP.P. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12.NPJ Breast Cancer201731610.1038/s41523‑017‑0008‑8 28649646
     [Google Scholar]
  75. GiannoudisA. ClarkeK. ZakariaR. VarešlijaD. FarahaniM. RainbowL. Platt-HigginsA. RuthvenS. BroughamK.A. RudlandP.S. JenkinsonM.D. YoungL.S. FalcianiF. PalmieriC. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.Sci. Rep.2019911851810.1038/s41598‑019‑55084‑z 31811234
     [Google Scholar]
  76. ZariA.T. ZariT.A. HakeemK.R. Anticancer properties of eugenol: A review.Molecules20212623740710.3390/molecules26237407 34885992
     [Google Scholar]
  77. ChenniM. El AbedD. RakotomanomanaN. FernandezX. ChematF. Comparative study of essential oils extracted from Egyptian basil leaves (Ocimum basilicum L.) using hydro-distillation and solvent-free microwave extraction.Molecules201621111310.3390/molecules21010113 26797599
     [Google Scholar]
  78. Al-TradB. AlkhateebH. AlsmadiW. Al-ZoubiM. Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat.Life Sci.201921618318810.1016/j.lfs.2018.11.034 30448265
     [Google Scholar]
  79. da Silva BruckmannF. VianaA.R. LopesL.Q.S. SantosR.C.V. MullerE.I. MortariS.R. RhodenC.R.B. Synthesis, characterization, and biological activity evaluation of magnetite-functionalized eugenol.J. Inorg. Organomet. Polym. Mater.20223241459147210.1007/s10904‑021‑02207‑7
     [Google Scholar]
  80. YiJ.L. ShiS. ShenY.L. WangL. ChenH.Y. ZhuJ. DingY. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.Int. J. Clin. Exp. Pathol.20158211161127 25972998
     [Google Scholar]
  81. ImranM. RaufA. Abu-IzneidT. NadeemM. ShariatiM.A. KhanI.A. ImranA. OrhanI.E. RizwanM. AtifM. GondalT.A. MubarakM.S. Luteolin, a flavonoid, as an anticancer agent: A review.Biomed. Pharmacother.201911210861210.1016/j.biopha.2019.108612 30798142
     [Google Scholar]
  82. NwezeE. EzeE. Justification for the use of Ocimum gratissimum L in herbal medicine and its interaction with disc antibiotics.BMC Complement. Altern. Med.200993710.1186/1472‑6882‑9‑37
     [Google Scholar]
  83. KhalilA.A. RahmanU. KhanM.R. SaharA. MehmoodT. KhanM. Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives.RSC Advances2017752326693268110.1039/C7RA04803C
     [Google Scholar]
  84. El-Saber BatihaG. Magdy BeshbishyA. El-MleehA. Abdel-DaimM.M. Prasad DevkotaH. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae).Biomolecules202010335210.3390/biom10030352 32106571
     [Google Scholar]
  85. MarcheseA. BarbieriR. CoppoE. OrhanI.E. DagliaM. NabaviS.F. IzadiM. AbdollahiM. NabaviS.M. AjamiM. Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint.Crit. Rev. Microbiol.201743666868910.1080/1040841X.2017.1295225 28346030
     [Google Scholar]
  86. AggarwalB.B. PrasadS. ReuterS. KannappanR. YadevV.R. ParkB. KimJ.H. GuptaS.C. PhromnoiK. SundaramC. PrasadS. ChaturvediM.M. SungB. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “Reverse pharmacology” and “bedside to bench” approach.Curr. Drug Targets201112111595165310.2174/138945011798109464 21561421
     [Google Scholar]
  87. KamatouG.P. VermaakI. ViljoenA.M. Eugenol--from the remote Maluku Islands to the international market place: A review of a remarkable and versatile molecule.Molecules20121766953698110.3390/molecules17066953 22728369
     [Google Scholar]
  88. YadavM.K. ChaeS.W. Im, G.J.; Chung, J.W.; Song, J.J. Eugenol: A phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms.PLoS One2015103e011956410.1371/journal.pone.0119564 25781975
     [Google Scholar]
  89. PattanayakP. BeheraP. DasD. PandaS. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview.Pharmacogn. Rev.2010479510510.4103/0973‑7847.65323 22228948
     [Google Scholar]
  90. FalagasM.E. BliziotisI.A. Pandrug-resistant Gram-negative bacteria: The dawn of the post-antibiotic era?Int. J. Antimicrob. Agents200729663063610.1016/j.ijantimicag.2006.12.012 17306965
     [Google Scholar]
  91. WangcharoenW. WallayaM. Antioxidant capacity and phenolic content of chilies.Agric. Nat. Resour.200741561569
     [Google Scholar]
  92. RahmanS. IslamR. AlamK. HenaM.A. JamalM. Ocimum sanctum L.: A review of phytochemical and pharmacological profile. In: Am J Drug Discov. Dev.,2011
     [Google Scholar]
  93. UgboguO.C. EmmanuelO. AgiG.O. IbeC. EkweoguC.N. UdeV.C. UcheM.E. NnannaR.O. UgboguE.A. A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.).Heliyon2021711e0840410.1016/j.heliyon.2021.e08404 34901489
     [Google Scholar]
  94. HasanM.R. AlotaibiB.S. AlthafarZ.M. MujamammiA.H. JameelaJ. An update on the therapeutic anticancer potential of Ocimum sanctum L.: “Elixir of Life”.Molecules2023283119310.3390/molecules28031193 36770859
     [Google Scholar]
  95. KelmM.A. NairM.G. StrasburgG.M. DeWittD.L. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.Phytomedicine20007171310.1016/S0944‑7113(00)80015‑X 10782484
     [Google Scholar]
  96. GeethaR.K. KedlayaR. VasudevanD.M. Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: In vivo and in vitro studies.Life Sci.2004761212810.1016/j.lfs.2004.05.036 15532130
     [Google Scholar]
  97. SivaM. ShanmugamK.R. ShanmugamB. Venkata SubbaiahG. RaviS. SathyaveluR. K. Ocimum sanctum: A review on the pharmacological properties.Int. J. Basic Clin. Pharmacol.20165255856510.18203/2319‑2003.ijbcp20161454
     [Google Scholar]
  98. GholapS. KarA. Hypoglycaemic effects of some plant extracts are possibly mediated through inhibition in corticosteroid concentration.Pharmazie20045911876878 15587591
     [Google Scholar]
  99. ArunaK. SivaramakrishnanV.M. Anticarcinogenic effects of some Indian plant products.Food Chem. Toxicol.1992301195395610.1016/0278‑6915(92)90180‑S 1473788
     [Google Scholar]
  100. GanasoundariA. UmaD.P. RaoB.S.S. Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum.Mutat. Res.1998397230331210.1016/S0027‑5107(97)00230‑3 9541656
     [Google Scholar]
  101. ZahranE.M. AbdelmohsenU.R. AyoubA.T. SalemM.A. KhalilH.E. DesoukeyS.Y. FouadM.A. KamelM.S. Metabolic profiling, histopathological anti-ulcer study, molecular docking and molecular dynamics of ursolic acid isolated from Ocimum forskolei Benth. (family Lamiaceae).S. Afr. J. Bot.202013131131910.1016/j.sajb.2020.03.004
     [Google Scholar]
  102. MedirattaP.K. SharmaK.K. SinghS. Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action.J. Ethnopharmacol.2002801152010.1016/S0378‑8741(01)00373‑7 11891082
     [Google Scholar]
  103. BehbahaniM. Evaluation of in vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris.PLoS One2014912e11604910.1371/journal.pone.0116049 25548920
     [Google Scholar]
  104. SrideviM. KalaiarasiP. PugalendiK.V. Antihyperlipidemic activity of alcoholic leaf extract of Solanum surattense in streptozotocin-diabetic rats.Asian Pac. J. Trop. Biomed.201112S276S28010.1016/S2221‑1691(11)60171‑8
     [Google Scholar]
  105. AbdullahM.L. HafezM.M. Al-HoshaniA. Al-ShabanahO. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.BMC Complement. Altern. Med.201818132110.1186/s12906‑018‑2392‑5 30518369
     [Google Scholar]
  106. RavindranR. DeviR.S. SamsonJ. SenthilvelanM. Noise-stress-induced brain neurotransmitter changes and the effect of Ocimum sanctum (Linn) treatment in albino rats.J. Pharmacol. Sci.200598435436010.1254/jphs.FP0050127 16113498
     [Google Scholar]
  107. ManikandanP. VinothiniG. VidyaP.R. PrathibaD. NaginiS. Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.Invest. New Drugs201129111011710.1007/s10637‑009‑9345‑2 19851710
     [Google Scholar]
  108. SoodS. NarangD. ThomasM.K. GuptaY.K. MaulikS.K. Effect of Ocimum sanctum Linn. on cardiac changes in rats subjected to chronic restraint stress.J. Ethnopharmacol.2006108342342710.1016/j.jep.2006.06.010 16965878
     [Google Scholar]
  109. ChniguirA. SaguemM.H. El-BennaJ. BachoualR. Eugenol inhibits neutrophil myeloperoxidase in vitro and attenuates LPS-induced lung inflammation in mice.Pharmaceuticals2022174504
     [Google Scholar]
  110. PetrocelliG. FarabegoliF. ValeriiM.C. GiovanniniC. SardoA. SpisniE. Molecules present in plant essential oils for prevention and treatment of colorectal cancer (CRC).Molecules202126488510.3390/molecules26040885 33567547
     [Google Scholar]
  111. ThirugnanasampandanR. ManaharanT. JayakumarR. KanthimathiM.S. RamyaG. RamnathM. Purified essential oil from Ocimum sanctum Linn. triggers the apoptotic mechanism in human breast cancer cells.Pharmacogn. Mag.20161246Suppl. 332710.4103/0973‑1296.185738 27563220
     [Google Scholar]
  112. GuravT.P. DholakiaB.B. GiriA.P. A glance at the chemodiversity of Ocimum species: Trends, implications, and strategies for the quality and yield improvement of essential oil.Phytochem. Rev.202221387991310.1007/s11101‑021‑09767‑z 34366748
     [Google Scholar]
  113. LegaultJ. PichetteA. Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel.J. Pharm. Pharmacol.200759121643164710.1211/jpp.59.12.0005 18053325
     [Google Scholar]
  114. AlmaM.H. MaviA. YildirimA. DigrakM. HirataT. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey.Biol. Pharm. Bull.200326121725172910.1248/bpb.26.1725 14646179
     [Google Scholar]
  115. Al-FatlawiA.A. AhmadA. Cytotoxicity and pro-apoptotic activity of carvacrol on human breast cancer cell line MCF-7.World J Pharm Sci.2014211341141
     [Google Scholar]
  116. YehyaA.H.S. AsifM. Abdul MajidA.M.S. OonC.E. Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.Biomed. J.202144669470810.1016/j.bj.2020.05.015 35166208
     [Google Scholar]
  117. KimS.S. OhO.J. MinH.Y. ParkE.J. KimY. ParkH.J. Nam HanY. LeeS.K. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells.Life Sci.200373333734810.1016/S0024‑3205(03)00288‑1 12757841
     [Google Scholar]
  118. MariA. ManiG. NagabhishekS.N. BalaramanG. SubramanianN. MirzaF.B. SundaramJ. ThiruvengadamD. Carvacrol promotes cell cycle arrest and apoptosis through PI3K/AKT signaling pathway in MCF-7 breast cancer cells.Chin. J. Integr. Med.202127968068710.1007/s11655‑020‑3193‑5 32572774
     [Google Scholar]
  119. XuZ. HanX. OuD. LiuT. LiZ. JiangG. LiuJ. ZhangJ. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.Appl. Microbiol. Biotechnol.2020104257558710.1007/s00253‑019‑10257‑8 31832711
     [Google Scholar]
  120. IqbalJ. AbbasiB.A. AhmadR. MahmoodT. KanwalS. AliB. KhalilA.T. ShahS.A. AlamM.M. BadshahH. Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications.Biomed. Pharmacother.201810875275610.1016/j.biopha.2018.09.096 30248543
     [Google Scholar]
  121. NunesS. MadureiraA.R. CamposD. SarmentoB. GomesA.M. PintadoM. ReisF. Therapeutic and nutraceutical potential of rosmarinic acid-Cytoprotective properties and pharmacokinetic profile.Crit. Rev. Food Sci. Nutr.201757917991806 26114303
     [Google Scholar]
  122. MagalhãesD.B. CastroI. Lopes-RodriguesV. PereiraJ.M. BarrosL. FerreiraI.C.F.R. XavierC.P.R. VasconcelosM.H. Melissa officinalis L. ethanolic extract inhibits the growth of a lung cancer cell line by interfering with the cell cycle and inducing apoptosis.Food Funct.2018963134314210.1039/C8FO00446C 29790547
     [Google Scholar]
  123. PetersenM. SimmondsM.S. Rosmarinic acid.Phytochemistry200362212112510.1016/S0031‑9422(02)00513‑7 12482446
     [Google Scholar]
  124. AlagawanyM. Abd El-HackM.E. FaragM.R. GopiM. KarthikK. MalikY.S. DhamaK. Rosmarinic acid: Modes of action, medicinal values and health benefits.Anim. Health Res. Rev.201718216717610.1017/S1466252317000081 29110743
     [Google Scholar]
  125. ZhaoJ. XuL. JinD. XinY. TianL. WangT. ZhaoD. WangZ. WangJ. Rosmarinic acid and related dietary supplements: Potential applications in the prevention and treatment of cancer.Biomolecules20221210141010.3390/biom12101410 36291619
     [Google Scholar]
  126. More-AdateP. LokhandeK.B. ShrivastavaA. DoiphodeS. NagarS. SinghA. BahetiA. Pharmacoinformatics approach for the screening of Kovidra (Bauhinia variegata) phytoconstituents against tumor suppressor protein in triple negative breast cancer.J. Biomol. Struct. Dyn.20244284263428210.1080/07391102.2023.2219744 37288734
     [Google Scholar]
  127. SharmaN. SharmaA. BhatiaG. LandiM. BresticM. SinghB. SinghJ. KaurS. BhardwajR. Isolation of phytochemicals from Bauhinia variegata L. bark and their in vitro antioxidant and cytotoxic potential.Antioxidants201981049210.3390/antiox8100492 31627372
     [Google Scholar]
  128. Abdel-HalimA.H. FyiadA.A. AboulthanaW.M. YoussefA.M. SabryN.M. KhalilW.K.B. AliM.M. Evaluation of the therapeutic effect of nano-gold Bauhinia variegata leaves extract against breast cancer-induced rats.Int J Pharm Res2021132246710.31838/ijpr/2021.13.02.336
     [Google Scholar]
  129. KamalY. KhanT. FatimaN. ShahzadiI. Ihsan, Ul-Haq; Anaya-Eugenio, G.D.; Arellano, E.D.S.; Bashir, K.; de Blanco, E.J.C. Assessment of cytotoxic potential of newly isolated Betulinic triterpenes from the Bark of Bauhinia variegata Linn. (Caesalpiniaceae).S. Afr. J. Bot.202315941942410.1016/j.sajb.2023.05.026
     [Google Scholar]
  130. MohamadouH. LienouL.L. TagneR.S. KadaH.P. EmboloE.L.E. NganwaG.K. EssameJ.L.O. JazetP.M.D. Phytochemical analysis and antioxidant activity of aqueous and hydroethanolic extracts from three anticancerous Fabaceae of Northern Cameroon pharmacopoeia.J. Biosci. Med.2024126193210.4236/jbm.2024.126004
     [Google Scholar]
  131. MahmoudK. Ahmed A FS. Marwa MM. Zeinab AE. Salwa ME.H. WalidF. May AE.M. YoussefE.M. Cell based and in vivo systematic evaluation of some Egyptian plant extracts targeting breast cancer.Toxicon202424410775210.1016/j.toxicon.2024.107752 38761923
     [Google Scholar]
/content/journals/acamc/10.2174/0118715206375507250603074251
Loading
Exploring the Therapeutic Potential of Ocimum sanctum and Phanera variegata in Breast Cancer Treatment: A Promising Natural Approach
Anti-Cancer Agents in Medicinal Chemistry 26, 239 (2026); https://doi.org/10.2174/0118715206375507250603074251
/content/journals/acamc/10.2174/0118715206375507250603074251
/content/journals/acamc/10.2174/0118715206375507250603074251
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Breast cancer; herbal approach; holy basil; mitochondrial pathway; Ocimum sanctum; Phanera variegata

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test